ClassID:

94386

C07D231/56 - page 3 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems Benzopyrazoles; Hydrogenated benzopyrazoles

Recent Application in this class:
#601
20160297767
2016-10-13

Estrogen receptor modulators and uses thereof

#602
20160289207
2016-10-06

Compounds inhibiting leucine-rich repeat kinase enzyme activity

#603
20160289196
2016-10-06

Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same

#604
20160280681
2016-09-29

N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors

#605
20160280671
2016-09-29

Compositions for the treatment of hypertension and/or fibrosis

#606
20160272617
2016-09-22

SUBSTITUTED PHENYLALANINE DERIVATIVES

#607
20160264517
2016-09-15

3-aminocyclopentane carboxamide derivatives

#608
20160259242
2016-09-08

Onium salt compound, resist composition, and pattern forming process

#609
20160257674
2016-09-08

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#610
20160257641
2016-09-08

Alkylene derivatives

#611
20160251339
2016-09-01

Aromatic heterocyclic compounds and their application in pharmaceuticals

#612
20160251307
2016-09-01

Aryl ethers and uses thereof

#613
20160244464
2016-08-25

SUBSTITUTED BENZENE COMPOUNDS

#614
20160244437
2016-08-25

SUBSTITUTED PHENYLALANINE DERIVATIVES

#615
20160237067
2016-08-18

SUBSTITUTED PHENYLALANINE DERIVATIVES

#616
20160229830
2016-08-11

Glucosylceramide synthase inhibitors for the treatment of diseases

#617
20160229809
2016-08-11

Heterocyclic vinyl autotaxin inhibitor compounds

#618
20160221959
2016-08-04

Antibacterial 2H-indazole derivatives

#619
20160216275
2016-07-28

Difference gel electrophoresis of phosphoproteome

#620
20160214973
2016-07-28

Store overload-induced calcium release inhibitors and methods for producing and using the same

#621
20160207916
2016-07-21

Naphthylurea derivatives and medical applications thereof

#622
20160185818
2016-06-30

Bidentate-binding modulators of LRRK2 and JNK kinases

#623
20160185716
2016-06-30

Selective histone deactylase 6 inhibitors

#624
20160176806
2016-06-23

Compounds

#625
20160168140
2016-06-16

HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS

#626
20160157491
2016-06-09

Pesticide compounds

#627
20160152576
2016-06-02

AKT PROTEIN KINASE INHIBITORS

#628
20160145247
2016-05-26

Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof

#629
20160145220
2016-05-26

Nitrogen-containing saturated heterocyclic compound

#630
20160137652
2016-05-19

Immunoregulatory agents

#631
20160130215
2016-05-12

Cyclopropaneamine compound

#632
20160130214
2016-05-12

1,3-diaminocyclopentane carboxamide derivatives

#633
20160122290
2016-05-05

Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

#634
20160108019
2016-04-21

Inhibitors of KRAS G12C mutant proteins

#635
20160095856
2016-04-07

Substituted indazole derivatives active as kinase inhibitors

#636
20160084859
2016-03-24

Detection of indazole synthetic cannabinoids

#637
20160083354
2016-03-24

Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same

#638
20160081334
2016-03-24

Herbicidally active 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds and derivatives thereof

#639
20160074381
2016-03-17

Modulators of cellular adhesion

#640
20160067259
2016-03-10

Selective HDAC1 and HDAC2 inhibitors

#641
20160060264
2016-03-03

Urea derivatives and uses thereof

#642
20160046649
2016-02-18

N-alkyl-2-phenoxyethanamines, their preparation and use

#643
20160046612
2016-02-18

Heterocyclic derivative and pharmaceutical drug

#644
20160045511
2016-02-18

Kinase inhibitors and method of treating cancer

#645
20160039788
2016-02-11

Deoxyuridine triphosphatase inhibitors

#646
20160039770
2016-02-11

Crystalline forms of an estrogen receptor modulator

#647
20160039745
2016-02-11

Histone deacetylase inhibitors and compositions and methods of use thereof

#648
20160031907
2016-02-04

Substituted Benzene Compounds

#649
20160031899
2016-02-04

SHIP1 modulators and methods related thereto

#650
20160031876
2016-02-04

Histone deacetylase inhibitors and compositions and methods of use thereof

#651
20160031823
2016-02-04

HDAC inhibitors

#652
20160024081
2016-01-28

Substituted 6,5-fused bicyclic heteroaryl compounds

#653
20160024017
2016-01-28

Arginine methyltransferase inhibitors and uses thereof

#654
20160022742
2016-01-28

Medicament for liver regeneration and for treatment of liver failure

#655
20160016910
2016-01-21

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#656
20160016893
2016-01-21

Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods

#657
20160009760
2016-01-14

Ligands for antibody and Fc-fusion protein purification by affinity chromotography IV

#658
20160002210
2016-01-07

Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof

#659
20160002195
2016-01-07

Cannabinergic nitrate esters and related analogs

#660
20160002188
2016-01-07

NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN

#661
20150376173
2015-12-31

Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#662
20150361075
2015-12-17

Compounds that modulate intracellular calcium

#663
20150353504
2015-12-10

Substituted indazole derivatives as in vitro MAO-B inhibitors

#664
20150353503
2015-12-10

Indazole derivatives and uses thereof

#665
20150346227
2015-12-03

Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family

#666
20150344472
2015-12-03

SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

#667
20150344437
2015-12-03

Pyrazolone derivatives as nitroxyl donors

#668
20150329493
2015-11-19

OMEGA-AMINO ACID DERIVATIVES OF BENZENE, PYRIDINE, AND PYRIDAZINE COMPOUNDS

#669
20150322024
2015-11-12

Substituted cinnamic acid amides for treating pain

#670
20150322002
2015-11-12

N-substituted benzamides and methods of use thereof

#671
20150299191
2015-10-22

Compounds and methods for inhibiting fascin

#672
20150299189
2015-10-22

Amine derivative or salt thereof

#673
20150299130
2015-10-22

Selective HDAC3 inhibitors

#674
20150297586
2015-10-22

Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives

#675
20150297566
2015-10-22

RORgammaT inhibitors

#676
20150291584
2015-10-15

GPR40 receptor agonist, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent

#677
20150291551
2015-10-15

Ingenol-3-acylates III and ingenol-3-carbamates

#678
20150291549
2015-10-15

Compounds useful as immunomodulators

#679
20150284389
2015-10-08

N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels

#680
20150284376
2015-10-08

Mineralocorticoid receptor antagonists

#681
20150266859
2015-09-24

Glucagon receptor modulators

#682
20150266825
2015-09-24

5-substituted indazole-3-carboxamides and preparation and use thereof

#683
20150259296
2015-09-17

Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin

#684
20150259282
2015-09-17

Potassium channel blockers

#685
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

#686
20150246916
2015-09-03

Substituted 6, 5-fused bicyclic heteroaryl compounds

#687
20150239847
2015-08-27

Heterocyclic compounds as pesticides

#688
20150225335
2015-08-13

Hydroxamic acid derivative

#689
20150218169
2015-08-06

3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof

#690
20150218159
2015-08-06

Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis B

#691
20150218096
2015-08-06

4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof

#692
20150210689
2015-07-30

Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation

#693
20150210687
2015-07-30

N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof

#694
20150203490
2015-07-23

Ring-fused compound

#695
20150191463
2015-07-09

Difluoromethylene compound

#696
20150191455
2015-07-09

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#697
20150191434
2015-07-09

3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof

#698
20150183775
2015-07-02

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#699
20150182503
2015-07-02

Mineralocorticoid receptor antagonists

#700
20150181880
2015-07-02

Fused heterocyclic compound

#701
20150175622
2015-06-25

3-O-heteroaryl-ingenol

#702
20150175592
2015-06-25

Viral polymerase inhibitors

#703
20150158876
2015-06-11

Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

#704
20150152088
2015-06-04

ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF

#705
20150152064
2015-06-04

METHODS AND COMPOSITIONS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION

#706
20150152063
2015-06-04

Indazole guanidine FF-ATPase inhibitors and therapeutic uses thereof

#707
20150148347
2015-05-28

Indanyloxyphenylcyclopropanecarboxylic acids

#708
20150148330
2015-05-28

Carbamate compounds and of making and using same

#709
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#710
20150141477
2015-05-21

Pyrazole derivatives and their use as LPAR5 antagonists

#711
20150133677
2015-05-14

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#712
20150126553
2015-05-07

BICYCLIC HETEROCYCLES CAPABLE OF MODULATING T-CELL RESPONSES, AND METHODS OF USING SAME

#713
20150119439
2015-04-30

Saturated acyl guanidine for inhibition of FF-ATPase

#714
20150111891
2015-04-23

Naphthalene acetic acid derivatives against HIV infection

#715
20150105403
2015-04-16

Estrogen receptor modulators and uses thereof

#716
20150080434
2015-03-19

Phenyl and benzodioxinyl substituted indazoles derivatives

#717
20150072986
2015-03-12

Urea derivatives and uses thereof

#718
20150072974
2015-03-12

D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders

#719
20150065520
2015-03-05

Substituted indazole derivatives active as kinase inhibitors

#720
20150065445
2015-03-05

Viral polymerase inhibitors

#721
20150057292
2015-02-26

Substituted indazole derivatives active as kinase inhibitors

#722
20150057291
2015-02-26

Substituted indazole derivatives active as kinase inhibitors

#723
20150057248
2015-02-26

Bivalent AMPA receptor positive allosteric modulators

#724
20150045398
2015-02-12

ArylSulfonamide-based matrix metalloprotease inhibitors

#725
20150045343
2015-02-12

Kinase inhibitors

#726
20150031681
2015-01-29

1-substituted indazole derivative

#727
20150030673
2015-01-29

Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride

#728
20150018337
2015-01-15

N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamides

#729
20150018335
2015-01-15

Carbamate compounds and of making and using same

#730
20150018331
2015-01-15

Antibacterial agents

#731
20150005500
2015-01-01

Ruthenium catalysts and their use for asymmetric reduction of ketones

#732
20150005279
2015-01-01

Primary carboxamides as BTK inhibitors

#733
20150005232
2015-01-01

Indazole derivatives

#734
20140371467
2014-12-18

Glucagon receptor modulators

#735
20140371261
2014-12-18

Indomethacin analogs for the treatment of castrate-resistant prostate cancer

#736
20140371202
2014-12-18

Indazole compounds as kinase inhibitors and method of treating cancer with same

#737
20140364393
2014-12-11

Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors

#738
20140343037
2014-11-20

Benzene, pyridine, and pyridazine derivatives

#739
20140336440
2014-11-13

Inhibitors of rho associated protein kinases (ROCK) and methods of use

#740
20140336224
2014-11-13

Mineralocorticoid receptor antagonists

#741
20140336170
2014-11-13

Indazole compounds useful as ketohexokinase inhibitors

#742
20140323475
2014-10-30

EP1 receptor ligands

#743
20140315945
2014-10-23

Substituted benzene compounds

#744
20140315889
2014-10-23

HYDROXAMATE DERIVATIVES FOR HDAC INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THEREOF

#745
20140303186
2014-10-09

Nitrogen-containing fused ring compounds as CRTH2 antagonists

#746
20140296283
2014-10-02

Substituted 6,5-fused bicyclic heteroaryl compounds

#747
20140288124
2014-09-25

Arginine methyltransferase inhibitors and uses thereof

#748
20140288090
2014-09-25

N-ARYLYLMETHYLINDAZOLE MODULATORS OF PPARG

#749
20140275172
2014-09-18

Benzo-fused heterocyclic derivatives useful as agonists of GPR120

#750
20140249151
2014-09-04

Bicyclic heterocyclic compound

#751
20140249148
2014-09-04

Selective HDAC3 inhibitors

#752
20140243366
2014-08-28

Compounds that modulate intracellular calcium

#753
20140243349
2014-08-28

γ-diketones as WNT/β-catenin signaling pathway activators

#754
20140243345
2014-08-28

Selective HDAC3 inhibitors

#755
20140243310
2014-08-28

Bicyclic compound

#756
20140228405
2014-08-14

Cyclopropaneamine compound

#757
20140228378
2014-08-14

N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists

#758
20140228351
2014-08-14

Substituted indazole derivatives active as kinase inhibitors

#759
20140221339
2014-08-07

Heterocyclic derivative and pharmaceutical drug

#760
20140221337
2014-08-07

Potassium channel blockers

#761
20140220050
2014-08-07

Immunomodulator and anti-inflammatory compounds

#762
20140187531
2014-07-03

Apoptosis promoters

#763
20140171469
2014-06-19

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#764
20140148436
2014-05-29

AKT PROTEIN KINASE INHIBITORS

#765
20140141510
2014-05-22

Medicament for liver regeneration and for treatment of liver failure

#766
20140128391
2014-05-08

Selective HDAC1 and HDAC2 inhibitors

#767
20140121244
2014-05-01

1-substituted indazole derivative

#768
20140107119
2014-04-17

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#769
20140088106
2014-03-27

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#770
20140088094
2014-03-27

N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

#771
20140080862
2014-03-20

Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof

#772
20140080807
2014-03-20

Substituted indazole derivatives active as kinase inhibitors

#773
20140066621
2014-03-06

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#774
20140066476
2014-03-06

Modulators of cellular adhesion

#775
20140057890
2014-02-27

BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#776
20140057889
2014-02-27

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#777
20140051679
2014-02-20

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

#778
20140051675
2014-02-20

Modulators of cellular adhesion

#779
20140045903
2014-02-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#780
20140045859
2014-02-13

Glucokinase activators

#781
20140045838
2014-02-13

Kinase inhibitors and method of treating cancer

#782
20140038942
2014-02-06

RORgammaT inhibitors

#783
20140024657
2014-01-23

Small molecule inhibitors of necroptosis

#784
20140011807
2014-01-09

Nitrogen-containing saturated heterocyclic compound

#785
20140005221
2014-01-02

Ring-fused compound

#786
20130345270
2013-12-26

METHODS OF TREATING CANCER AND OTHER DISORDERS

#787
20130338148
2013-12-19

Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

#788
20130331419
2013-12-12

Mineralocorticoid receptor antagonists

#789
20130324537
2013-12-05

Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

#790
20130324514
2013-12-05

Indanyloxyphenylcyclopropanecarboxylic acids

#791
20130303525
2013-11-14

Kappa opioid receptor agonists

#792
20130296355
2013-11-07

Glucagon receptor modulators

#793
20130296295
2013-11-07

BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases

#794
20130296281
2013-11-07

Aryl substituted indoles and their use as blockers of sodium channels

#795
20130289025
2013-10-31

PYRAZOLE-SUBSTITUTED ARYLAMIDES AS P2X3 AND P2X2/3 ANTAGONISTS

#796
20130274218
2013-10-17

Viral polymerase inhibitors

#797
20130274179
2013-10-17

Viral polymerase inhibitors

#798
20130267704
2013-10-10

1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40

#799
20130267493
2013-10-10

Indole and indazole compounds that activate AMPK

#800
20130261125
2013-10-03

Indazole derivatives useful as ERK inhibitors

#801
20130245033
2013-09-19

Amide compounds

#802
20130245022
2013-09-19

Heteroaryl-substituted urea modulators of fatty acid amide hydrolase

#803
20130245019
2013-09-19

Acrylomido derivatives useful as inhibitors of the mitochondrial permeability transition

#804
20130245015
2013-09-19

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#805
20130231333
2013-09-05

Estrogen receptor modulators and uses thereof

#806
20130190509
2013-07-25

HSP90 inhibitor and preparation method and use thereof

#807
20130184463
2013-07-18

Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response

#808
20130184287
2013-07-18

Indazole compounds and their uses

#809
20130178630
2013-07-11

Process for making HCV protease inhibitors

#810
20130137679
2013-05-30

Functionally selective ligands of dopamine Dreceptors

#811
20130131321
2013-05-23

LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY

#812
20130131134
2013-05-23

Phenylpropionic acid derivative and use thereof

#813
20130123296
2013-05-16

LONIDAMINE ANALOGUES FOR FERTILITY MANAGEMENT

#814
20130109863
2013-05-02

Hetero-substituted acetanilide derivatives as analgesic agents

#815
20130109657
2013-05-02

C7-fluoro substituted tetracycline compounds

#816
20130096301
2013-04-18

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#817
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#818
20130072677
2013-03-21

Hydroxamic acid derivative

#819
20130040976
2013-02-14

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

#820
20130040389
2013-02-14

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#821
20130035487
2013-02-07

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#822
20130035325
2013-02-07

KINASE INHIBITORS

#823
20130030189
2013-01-31

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#824
20130018075
2013-01-17

HETEROCYCLIC INHIBITORS OF MEK AND METHODS OF USE THEREOF

#825
20130018036
2013-01-17

Substituted indazole derivatives active as kinase inhibitors

#826
20130012561
2013-01-10

Estrogen receptor modulators and uses thereof

#827
20130012536
2013-01-10

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#828
20120329794
2012-12-27

Ab1 KINASE INHIBITORS

#829
20120322842
2012-12-20

HETEROCYCYL-SUBSTITUTED-ALKYLAMINOPHENYL DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS

#830
20120322841
2012-12-20

Aldosterone synthase inhibitor

#831
20120316185
2012-12-13

Cyclohexyl amide derivatives as CRF receptor antagonists

#832
20120302617
2012-11-29

Phenyl and benzodioxinyl substituted indazoles derivatives

#833
20120302597
2012-11-29

P2X7R antagonists and their use

#834
20120302527
2012-11-29

C7-fluoro substituted tetracycline compounds

#835
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#836
20120277258
2012-11-01

Chemical Compounds

#837
20120277190
2012-11-01

PRODRUGS OF COMPOUNDS THAT INHIBIT TRPV1 RECEPTOR

#838
20120270865
2012-10-25

Heterocyclic compound

#839
20120264800
2012-10-18

Kinase inhibitors and method of treating cancer

#840
20120264799
2012-10-18

INDANE-AMINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS

#841
20120263679
2012-10-18

Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use Thereof

#842
20120259120
2012-10-11

Diazonium-free method to make an indazole intermediate in the synthesis of bicyclic 5-(trifluormethoxy)-1H-3-indazolecarboxylic acid amides

#843
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#844
20120253036
2012-10-04

AGENT FOR TREATING FIBROMYALGIA

#845
20120252799
2012-10-04

Heterocyclic aromatic compounds useful as growth hormone secretagogues

#846
20120252770
2012-10-04

Chemical Compounds 572

#847
20120245163
2012-09-27

TRPV1 antagonists

#848
20120245138
2012-09-27

N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamides

#849
20120226051
2012-09-06

Organic dicarboxylic acids, salts and preparation method thereof

#850
20120225909
2012-09-06

INDAZOLE ANALOG

#851
20120225887
2012-09-06

Glucokinase Activators

#852
20120202834
2012-08-09

Glucagon receptor modulators

#853
20120202777
2012-08-09

C-linked hydroxamic acid derivatives useful as antibacterial agents

#854
20120190845
2012-07-26

Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

#855
20120184752
2012-07-19

Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required magnesium intermediates

#856
20120165377
2012-06-28

AGENT FOR REDUCING VISCERAL FAT WEIGHT

#857
20120149912
2012-06-14

Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required magnesium intermediates

#858
20120149750
2012-06-14

Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof

#859
20120149741
2012-06-14

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

#860
20120148534
2012-06-14

Methods and compositions of treating a family viral infection

#861
20120146015
2012-06-14

Charge transport materials for luminescent applications

#862
20120142686
2012-06-07

Viral polymerase inhibitors

#863
20120130069
2012-05-24

Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient

#864
20120122889
2012-05-17

SMALL MOLECULE INHIBITORS OF NECROPTOSIS

#865
20120122834
2012-05-17

Small molecule CD4 mimetics and uses thereof

#866
20120115915
2012-05-10

N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation

#867
20120108815
2012-05-03

Bifunctional/polyfunctional dopamine D2/D3 agonist as neuroprotective agents for treatment of neurodegenerative diseases

#868
20120108584
2012-05-03

2H or 3H-benzo[E]indazol-1-YL carbamate derivatives, the preparation and therapeutic use thereof

#869
20120101131
2012-04-26

Aminotetrahydroindazoloacetic acids

#870
20120095053
2012-04-19

Aminotetrahydroindazoloacetic acids

#871
20120094983
2012-04-19

Acyclic Iinhibitors

#872
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

#873
20120094971
2012-04-19

Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

#874
20120071535
2012-03-22

Estrogen receptor modulators and uses thereof

#875
20120065196
2012-03-15

AMIDE COMPOUNDS

#876
20120065173
2012-03-15

CHEMICAL COMPOUNDS

#877
20120064032
2012-03-15

Hydroxamates as therapeutic agents

#878
20120053173
2012-03-01

Heterocyclic compound

#879
20120046322
2012-02-23

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

#880
20120046255
2012-02-23

Non-steroidal compounds

#881
20120035179
2012-02-09

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#882
20120035154
2012-02-09

Modulators of Cellular Adhesion

#883
20120028963
2012-02-02

Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same

#884
20120022253
2012-01-26

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#885
20120016117
2012-01-19

INDAZOLEPROPIONIC ACID AMIDE COMPOUND

#886
20120015959
2012-01-19

Heterocyclic compounds as autotaxin inhibitors

#887
20120010183
2012-01-12

Sulfonamide derivatives as Nav 1.7 inhibitors

#888
20120004412
2012-01-05

Methods for the preparation of N-(S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride salt

#889
20110319379
2011-12-29

Substituted Indazole Amides And Their Use As Glucokinase Activators

#890
20110313003
2011-12-22

GPR120 receptor agonists and uses thereof

#891
20110301155
2011-12-08

INDAZOLE COMPOUNDS FOR ACTIVATING GLUCOKINASE

#892
20110301082
2011-12-08

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

#893
20110294808
2011-12-01

Indazole compounds as CCR1 receptor antagonists

#894
20110288092
2011-11-24

Heterocyclic Inhibitors of MEK and Methods of Use Thereof

#895
20110281843
2011-11-17

Substituted indazole derivatives active as kinase inhibitors

#896
20110275609
2011-11-10

Bicyclic pyrazolo-heterocycles

#897
20110275603
2011-11-10

Immunomodulator and anti-inflammatory compounds

#898
20110263662
2011-10-27

1,2-DIAMIDO-ETHYLENE DERIVATIVES AS OREXIN ANTAGONISTS

#899
20110263598
2011-10-27

Kinase inhibitors and method of treating cancer

#900
20110263559
2011-10-27

Indazole compounds useful as ketohexokinase inhibitors